阿尔蒙尔蒂尼布作为一种新辅助疗法,用于具有激活EGFR突变的高级肺瘤患者:病例报告
Kai Kang1, Zhixiao Jiang1, Jindan Kai1
1Department of Thoracic Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430079, P.R. China.
Experimental and therapeutic medicine
|November 13, 2023
概括
这项研究提出了一个成功的案例,即用诱导化疗,向治疗和手术治疗Pancoast瘤. 患者在4个月后没有出现复发,这突显了这种晚期肺癌的有效治疗策略.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
背景情况:
- 上层肺瘤 (泛海岸瘤) 是局部发达的肺癌.
- 这些瘤侵入相邻的胸部结构,包括神经和血管.
- 标准治疗通常涉及诱导疗法,随后是手术.
更多相关视频
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
8.0K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.0K
